Cervical Compressive Myelopathy Treatment Guidelines
Introduction to Treatment Options
- For patients with mild cervical myelopathy, either surgical decompression or nonoperative therapy can be effective in the short term (3 years) 1, 2, 3
- Nonoperative therapy options for mild cervical myelopathy include prolonged immobilization, "low-risk" activity modification, anti-inflammatory medications, and physical therapy to strengthen neck muscles 1, 2, 3, 4
Treatment Algorithm Based on Disease Severity
- Surgical decompression is strongly recommended for moderate to severe cervical myelopathy (mJOA score ≤12) 1, 2, 5
- Benefits of surgery for moderate to severe cervical myelopathy are maintained for at least 5 years and up to 15 years postoperatively 2, 5
- Patients with severe myelopathy show significant improvement after surgical intervention 5
Surgical Approach Selection
- Anterior cervical discectomy and fusion (ACDF) is effective for 1-2 level disease, while anterior corpectomy is recommended for 3-segment disease 4
- Subtotal corpectomy with reconstruction can improve neurological scores from an average of 7.9 preoperatively to 13.4 at 15-year follow-up 5
- Laminoplasty preserves motion and reduces axial neck pain, while laminectomy with fusion prevents post-laminectomy kyphosis 4, 6
Complications and Considerations
- Post-surgical kyphosis occurs in approximately 10% of patients after laminoplasty, and C5 nerve palsy can develop after surgery, especially when laminae are elevated to an angle > 60° 4
- Pseudarthrosis can occur in approximately 10.9% of cases after corpectomy, and complications of laminectomy with fusion may include neurological deterioration, deep infection, and pseudarthrosis 4, 6, 7
Key Pitfalls to Avoid
- Delaying surgical intervention in patients with moderate to severe myelopathy can lead to irreversible spinal cord damage, and long periods of severe stenosis can result in potentially irreversible damage to the spinal cord 4
- Inadequate stabilization during surgery can lead to cage movement and pseudarthrosis 7
Treatment for Compressive Cervical Myelopathy
Surgical Approach Selection
- Laminectomy with fusion prevents post-laminectomy kyphosis and is recommended for ≥4-segment disease, according to the Journal of Neurosurgery 8
- Laminectomy with lateral mass fusion resulted in neurological improvement in 97% of patients with mean JOA score improvement from 12.9 to 15.6, as reported by the Journal of Neurosurgery 9
- Laminectomy and posterior fusion showed significantly greater rates of neurological recovery (average 2.0 Nurick grade improvement) compared to anterior approach (1.2 grade improvement) or laminectomy alone (0.9 grade improvement), as found by the Journal of Neurosurgery 8
Critical Pitfalls to Avoid
Timing-Related Complications
- Patients with symptoms present for less than one year before surgery show better results across all treatment modalities, according to the Journal of Neurosurgery 8
Technical Complications
- Laminectomy alone (without fusion) has a concerning trend of long-term late deterioration (29% rate) and should be avoided, as reported by the Journal of Neurosurgery 8
Surgical Intervention for Progressive Cervical Myelopathy
Introduction to Surgical Approaches
- The American College of Surgeons recommends ambulatory surgery for ACDF procedures, with complication rates of approximately 21%, unless severe complications occur or high-risk factors exist 10, 11
Surgical Approach Selection
- The use of spinal fixation devices, such as those used in CPT 22846, prevents post-operative kyphosis and provides stability, as described in the Journal of Neurosurgery 10
- Bone allograft, as used in CPT 20930, promotes fusion and prevents pseudarthrosis, according to the Journal of Neurosurgery 10, 11
Common Pitfalls to Avoid
- Laminectomy alone, without fusion, should be avoided due to concerning rates of late deterioration and risk of post-operative kyphosis, as reported in the Journal of Neurosurgery 10
- Inadequate stabilization can lead to cage movement and pseudarthrosis, occurring in approximately 10.9% of cases, and failure to address multilevel disease adequately may result in adjacent segment degeneration 10